Zealand Pharma A/S (CPH:ZEAL)
500.60
+15.40 (3.17%)
Nov 4, 2025, 4:59 PM CET
Zealand Pharma Revenue
Zealand Pharma had revenue of 9.09B DKK in the quarter ending June 30, 2025, with 26,527.65% growth. This brings the company's revenue in the last twelve months to 9.11B, up 2,375.69% year-over-year. In the year 2024, Zealand Pharma had annual revenue of 62.69M, down -81.71%.
Revenue (ttm)
9.11B
Revenue Growth
+2,375.69%
P/S Ratio
3.87
Revenue / Employee
21.49M
Employees
335
Market Cap
35.24B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 62.69M | -280.10M | -81.71% |
| Dec 31, 2023 | 342.79M | 238.80M | 229.65% |
| Dec 31, 2022 | 103.99M | -4.56M | -4.20% |
| Dec 31, 2021 | 108.55M | -83.46M | -43.47% |
| Dec 31, 2020 | 192.00M | 150.67M | 364.52% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Novo Nordisk | 311.94B |
| Coloplast | 27.87B |
| H. Lundbeck | 23.52B |
| Genmab | 23.16B |
| Demant | 22.59B |
| GN Store Nord | 17.33B |
| Bavarian Nordic | 6.46B |
| Ambu A/S | 5.96B |
Zealand Pharma News
- 18 days ago - Zealand Pharma major shareholder announcement: Van Herk Investments B.V. - GlobeNewsWire
- 5 weeks ago - Zealand Pharma A/S (ZLDPF) Presents at Bank of America Global Healthcare Conference 2025 Transcript - Seeking Alpha
- 5 weeks ago - Zealand Pharma appoints Rachel James-Owens as Vice President, Corporate Communications & Media Relations - GlobeNewsWire
- 6 weeks ago - Zealand Pharma may sell future obesity drug direct to patients, amid market shifts - Reuters
- 7 weeks ago - Zealand Pharma increases its share capital as a result of the exercise of employee warrants - GlobeNewsWire
- 7 weeks ago - SAVE THE DATE: Zealand Pharma to host Capital Markets Day in London on December 11, 2025 - GlobeNewsWire
- 2 months ago - Zealand Pharma A/S (ZLDPF) Presents at Cantor Global Healthcare Conference 2025 Transcript - Seeking Alpha
- 2 months ago - Zealand Pharma to participate in upcoming investor conferences in September 2025 - GlobeNewsWire